Clinical trial
The Effects of Lycopene on High Risk Prostatic Tissue
NCT01443026
Study timeline
Study start (unknown)2006-02-01Date precision: month
Registry last updated2019-11-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Intraepithelial Prostatic Neoplasiaunresolved
Prostatic Neoplasmsunresolved
Interventions
Lycopene 30mgDRUG
PlaceboDRUG
Sponsors & collaborators
University of Illinois at Chicagolead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01443026 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.